Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)

StatusRecruiting
PhaseNot applicable
SponsorSanofi
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Dec 25, 2026 → Jun 30, 2027
See other at-risk trials from Sanofi

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 25, 2026 to Jun 30, 2027
    • Eligibility criteria expanded, about 6 words
    • Site details revised at 1 of 7 sites
  2. Trial sites expanded: 2 → 7 locationsv6
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date changed from estimate of Dec 25, 2025 to Dec 17, 2025
    • Eligibility criteria expanded, about 20 words
    v5
  4. Start date: Nov 15, 2025 to Dec 25, 2025
    • Primary and study completion dates pushed to Dec 25, 2026
    v4
  5. Start date: Aug 31, 2025 to Nov 15, 2025v3
  6. Start date: Jul 18, 2025 to Aug 31, 2025
    • Study completion date: Jul 31, 2026 to Sep 1, 2026
    v2
  7. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Sanofi
286 trials monitored
See 13 trials at risk
Diabetes
5,141 trials monitored
See 246 trials at risk
Type 1 Diabetes
895 trials monitored
See 42 trials at risk
The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in young children and adolescents who have first degree relatives with T1D. This protocol has been developed to address the growing need for standardized T1D screening, monitoring, and data collection in alignment with international recommendations. The study's estimated duration is 13 months and will consist of two visits: Visit 1 (screening visit) and Visit 2 (confirmatory visit).
Trial Details
NCT Number NCT07038473
Lead Sponsor Sanofi
Conditions
(from sponsor)		 Type 1 Diabetes
Related terms Diabetes Mellitus, Type 1
Enrollment 3,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov